Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh. 2016

Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

BACKGROUND Enterotoxigenic Escherichia coli (ETEC) is a common cause of bacterial infection leading to acute watery diarrhea in infants and young children as well as in travellers to ETEC endemic countries. Ciprofloxacin is a broad-spectrum antimicrobial agent nowadays used for the treatment of diarrhea. This study aimed to characterize ciprofloxacin resistant ETEC strains isolated from diarrheal patients in Bangladesh. METHODS A total of 8580 stool specimens from diarrheal patients attending the icddr,b Dhaka hospital was screened for ETEC between 2005 and 2009. PCR and Ganglioside GM1- Enzyme Linked Immuno sorbent Assay (ELISA) was used for detection of Heat labile (LT) and Heat stable (ST) toxins of ETEC. Antimicrobial susceptibilities for commonly used antibiotics and the minimum inhibitory concentration (MIC) of nalidixic acid, ciprofloxacin and azithromycin were examined. DNA sequencing of representative ciprofloxacin resistant strains was performed to analyze mutations of the quinolone resistance-determining region of gyrA, gyrB, parC and parE. PCR was used for the detection of qnr, a plasmid mediated ciprofloxacin resistance gene. Clonal variations among ciprofloxacin resistant (CipR) and ciprofloxacin susceptible (CipS) strains were determined by Pulsed-field gel electrophoresis (PFGE). RESULTS Among 1067 (12%) ETEC isolates identified, 42% produced LT/ST, 28% ST and 30% LT alone. Forty nine percent (n = 523) of the ETEC strains expressed one or more of the 13 tested colonization factors (CFs) as determined by dot blot immunoassay. Antibiotic resistance of the ETEC strains was observed as follows: ampicillin 66%, azithromycin 27%, ciprofloxacin 27%, ceftriazone 13%, cotrimaxazole 46%, doxycycline 44%, erythromycin 96%, nalidixic acid 83%, norfloxacin 27%, streptomycin 48% and tetracycline 42%. Resistance to ciprofloxacin increased from 13% in 2005 to 34% in 2009. None of the strains was resistant to mecillinam. The MIC of the nalidixic acid and ciprofloxacin of representative CipR strains were 256 μg/ml and 32μg/ml respectively. A single mutation (Ser83-Leu) in gyrA was observed in the nalidixic acid resistant ETEC strains. In contrast, double mutation in gyrA (Ser83-Leu, Asp87-Asn) and a single mutation in parC (Glu84-Ly) were found in ciprofloxacin resistant strains. Mutation of gyrB was not found in either the nalidixic acid or ciprofloxacin resistant strains. None of the ciprofloxacin resistant strains was found to be positive for the qnr gene. Diverse clones were identified from all ciprofloxacin resistant strains by PFGE analysis in both CF positive and CF negative ETEC strains. CONCLUSIONS Emergence of ciprofloxacin resistant ETEC strains results in a major challenge in current treatment strategies of ETEC diarrhea.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001459 Bangladesh A country in Southern Asia, bordering the Bay of Bengal, between Burma and India. The capital is Dhaka.
D054307 Enterotoxigenic Escherichia coli Strains of ESCHERICHIA COLI that produce or contain at least one member of either heat-labile or heat-stable ENTEROTOXINS. The organisms colonize the mucosal surface of the small intestine and elaborate their enterotoxins causing DIARRHEA. They are mainly associated with tropical and developing countries and affect susceptible travelers to those places. E coli, Enterotoxigenic,ETEC,Escherichia coli, Enterotoxigenic,Enterotoxigenic E. coli

Related Publications

Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
March 2004, FEMS immunology and medical microbiology,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
July 2014, PLoS neglected tropical diseases,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
January 2015, PloS one,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
September 2000, Veterinary microbiology,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
October 2010, Journal of microbiological methods,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
April 2019, Scientific reports,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
January 1980, Medical microbiology and immunology,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
January 1999, Veterinary research,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
January 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
Yasmin A Begum, and K A Talukder, and Ishrat J Azmi, and Mohammad Shahnaij, and A Sheikh, and Salma Sharmin, and A-M Svennerholm, and Firdausi Qadri
September 1987, Canadian journal of microbiology,
Copied contents to your clipboard!